Access to Therapy
The NLA aims to provide its members with relevant information on therapies for lipid disorders and the barriers to using certain therapies in order to raise the standard of clinical lipidology and in turn provide enhanced care for patients. The NLA authors articles and creates practical tools to provide guidance on identifying the right patients for the right therapies and practical approaches to eliminate the associated barriers of use.
Resources
Introduction to Use of Tools- Letter from NLA Leadership
Checklist for Seeking Approval of PCSK9 Inhibitors
2017 Recommendations of the NLA Expert Panel on Treatment with PCSK9 Inhibitor
Challenges in Prescribing PCSK9 Inhibitors Survey Findings
EBM Tools for Practice: A NLA Best Practices Guide: PCSK9 Inhibitors
Other Languages
Sorry there are no other language resources available for this section.